122 related articles for article (PubMed ID: 3257943)
1. A prospective study of circulating immune complexes in patients with breast cancer.
Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serial determinations of circulating immune complex levels in malignant melanoma.
Bukh A; Møller-Larsen A; Aguado MT; Møller-Larsen F; Møller NP
Cancer Immunol Immunother; 1988; 26(3):280-4. PubMed ID: 3260134
[TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation.
Sølling J
Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):213-20. PubMed ID: 6391086
[TBL] [Abstract][Full Text] [Related]
6. Primary lung cancer. A controlled study of preoperative and postoperative levels of circulating immune complexes.
Bukh A; Aguado MT; Kimose HH; Mouritzen C; Møoller NP
Cancer; 1988 May; 61(10):2033-41. PubMed ID: 3258788
[TBL] [Abstract][Full Text] [Related]
7. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy.
Doi T; Kanatsu K; Sekita K; Yoshida H; Nagai H; Hamashima Y
J Immunol Methods; 1984 Apr; 69(1):95-104. PubMed ID: 6371143
[TBL] [Abstract][Full Text] [Related]
8. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
9. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
[TBL] [Abstract][Full Text] [Related]
11. Detection and quantitation of circulating immune complexes in arterial blood of patients with rheumatic disease.
Panush RS; Katz P; Longley S; Yonker RA
Clin Immunol Immunopathol; 1985 Aug; 36(2):217-26. PubMed ID: 3874034
[TBL] [Abstract][Full Text] [Related]
12. Circulating antigens, immune complexes and C3d levels in human schistosomiasis: relationship with Schistosoma mansoni egg output.
Santoro F; Prata A; Castro CN; Capron A
Clin Exp Immunol; 1980 Nov; 42(2):219-25. PubMed ID: 7471514
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
16. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity and composition of immune complexes in patients with rheumatoid arthritis, with special reference to IgE-containing immune complexes.
De Clerck LS; Struyf NJ; Bridts CH; Francx L; Van Offel JF; Empsten FA; Westedt ML; Breedveld FC; Cats A; Stevens WJ
Clin Exp Rheumatol; 1989; 7(5):485-92. PubMed ID: 2591122
[TBL] [Abstract][Full Text] [Related]
18. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
19. Search for circulating immune complexes and activation of the complement system in relation to estrogen treatment.
Bukh A; Jensen HK; Andersen HJ; Eriksen PB; Møller NP
Acta Obstet Gynecol Scand; 1987; 66(8):703-8. PubMed ID: 3329440
[TBL] [Abstract][Full Text] [Related]
20. Immune complexes and complement activation following rupture of intracranial saccular aneurysms.
Ostergaard JR; Kristensen BO; Svehag SE; Teisner B; Miletic T
J Neurosurg; 1987 Jun; 66(6):891-7. PubMed ID: 3494822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
